| Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.700 | GeneticVariation | UNIPROT | American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. | 24493721 | 2014 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. | 24893135 | 2014 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Canadian guideline on genetic screening for hereditary renal cell cancers. | 24319509 | 2013 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | |||||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. | 21156949 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. | 20154675 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. | 21156949 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. | 20154675 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. | 21156949 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. | 20154675 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. | 21156949 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. | 20154675 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. | 21156949 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. | 20154675 | 2010 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | |||||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Functional and in silico assessment of MAX variants of unknown significance. | 26070438 | 2015 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. | 24893135 | 2014 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. | 24493721 | 2014 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Canadian guideline on genetic screening for hereditary renal cell cancers. | 24319509 | 2013 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. | 22452945 | 2012 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. | 21685915 | 2011 |
||||||||
|
|
0.700 | GeneticVariation | UNIPROT | |||||||||||
|
|
0.700 | GeneticVariation | UNIPROT | |||||||||||
|
|
0.700 | GeneticVariation | UNIPROT | |||||||||||
|
|
0.700 | GeneticVariation | UNIPROT |